Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke

Journal of the Neurological Sciences

Volumn 267, Issue 1-2, 2008, Pages 57-61

  Kimura, Kazumi ^a   Iguchi, Yasuyuki ^a   Yamashita, Shinji ^a   Shibazaki, Kensaku ^a   Kobayashi, Kazuto ^a   Inoue, Takeshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Atrial fibrillation; MRI; Outcome; Recanalization; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL ARTERIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 39049169028     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.09.036     Document Type: Article

References (18)

1. Hacke W., Donnan G., Fieschi C., Kaste M., von Kummer R., Broderick J.P., et al. Association of outcome with early stroke treatment: pooled analysis of atlantis, ecass, and ninds rt-PA stroke trials. Lancet 363 (2004) 768-774
2. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. N Engl J Med 333 (1995) 1581-1587
3. Zangerle A., Kiechl S., Spiegel M., Furtner M., Knoflach M., Werner P., et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology 68 (2007) 39-44
4. Rubiera M., Alvarez-Sabin J., Ribo M., Montaner J., Santamarina E., Arenillas J.F., et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 36 (2005) 1452-1456
5. Molina C.A., Alexandrov A.V., Demchuk A.M., Saqqur M., Uchino K., and Alvarez-Sabin J. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 35 (2004) 151-156
6. Kim Y.S., Garami Z., Mikulik R., Molina C.A., and Alexandrov A.V. Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke 36 (2005) 869-871
7. Delgado-Mederos R., Rovira A., Alvarez-Sabin J., Ribo M., Munuera J., Rubiera M., et al. Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke. Stroke 38 (2007) 955-960
8. del Zoppo G.J., Poeck K., Pessin M.S., Wolpert S.M., Furlan A.J., Ferbert A., et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32 (1992) 78-86
9. Alexandrov A.V., Demchuk A.M., Felberg R.A., Christou I., Barber P.A., Burgin W.S., et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-mhz transcranial Doppler monitoring. Stroke 31 (2000) 610-614
10. Lewandowski C.A., Frankel M., Tomsick T.A., Broderick J., Frey J., Clark W., et al. Combined intravenous and intra-arterial rt-PA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke 30 (1999) 2598-2605
11. Smith W.S., Sung G., Starkman S., Saver J.L., Kidwell C.S., Gobin Y.P., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438
12. Smith W.S. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi mechanical embolus removal in cerebral ischemia (MERCI) trial, part i. AJNR. Am J Neuroradiol 27 (2006) 1177-1182
13. Yamaguchi T., Mori E., Minematsu K., Nakagawara J., Hashi K., Saito I., et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan alteplase clinical trial (J-ACT). Stroke 37 (2006) 1810-1815
14. Demchuk A.M., Felburg R.A., and Alexandrov A.V. Clinical recovery from acute ischemic stroke after early reperfusion of the brain with intravenous thrombolysis. N Engl J Med 340 (1999) 894-895
15. Albanese M.A., Clarke W.R., Adams Jr. H.P., and Woolson R.F. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the trial of org 10172 in acute stroke treatment (TOAST). Stroke 25 (1994) 1746-1751
16. Christou I., Alexandrov A.V., Burgin W.S., Wojner A.W., Felberg R.A., Malkoff M., et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 31 (2000) 1812-1816
17. Molina C.A., Montaner J., Arenillas J.F., Ribo M., Rubiera M., and Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 35 (2004) 486-490
18. Saito T., Tamura K., Uchida D., Nitta T., and Sugisaki Y. Histopathological evaluation of left atrial appendage thrombogenesis removed during surgery for atrial fibrillation. Am Heart J 153 (2007) 704-711